An example is the study of tumor-associated macrophages (TAMs) in MCC, and the association of S100A8-expressing TAMs with resistance to anti-PD-L1 inhibitors (where PD-L1 stands for programmed death-ligand 1). This evidence concerns the gene S100A8 and neoplasm.